KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Times Interest Earned: 2012-2024

Historic Times Interest Earned for Emergent BioSolutions (EBS) over the last 12 years, with Dec 2024 value amounting to -$1.53.

  • Emergent BioSolutions' Times Interest Earned fell 35.24% to $5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.99, marking a year-over-year increase of 208.68%. This contributed to the annual value of -$1.53 for FY2024, which is 81.47% up from last year.
  • Per Emergent BioSolutions' latest filing, its Times Interest Earned stood at -$1.53 for FY2024, which was up 81.47% from -$8.26 recorded in FY2023.
  • Emergent BioSolutions' 5-year Times Interest Earned high stood at $14.01 for FY2020, and its period low was -$8.26 during FY2023.
  • In the last 3 years, Emergent BioSolutions' Times Interest Earned had a median value of -$4.56 in 2022 and averaged -$4.78.
  • Per our database at Business Quant, Emergent BioSolutions' Times Interest Earned soared by 371.49% in 2020 and then slumped by 146.06% in 2022.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Times Interest Earned stood at $14.01 in 2020, then decreased by 29.37% to $9.90 in 2021, then slumped by 146.06% to -$4.56 in 2022, then tumbled by 81.32% to -$8.26 in 2023, then skyrocketed by 81.47% to -$1.53 in 2024.